The Thoracic and Cardiovascular Surgeon, Inhaltsverzeichnis Thorac Cardiovasc Surg 2011; 59(8): 454-459DOI: 10.1055/s-0030-1271028 Original Cardiovascular© Georg Thieme Verlag KG Stuttgart · New YorkLong-term Results of Mechanical and Biological Heart Valves in Dialysis and Non-Dialysis PatientsA. Böning1 , R.-H. Boedeker2 , U. P. Rosendahl3 , B. Niemann1 , S. Haberer1 , P. Roth1 , J. A. C. Ennker3 1Department of Cardiovascular Surgery, University Hospital Giessen, Giessen, Germany 2Justus-Liebig-University Giessen, Institute for Medical Statistics, Giessen, Germany 3Mediclin Heart Institute, Lahr, Germany Artikel empfehlen Abstract Artikel einzeln kaufen Alle Artikel dieser Rubrik Abstract Introduction: We wanted to answer the question whether biological heart valves are inferior compared to mechanical heart valves in end-stage renal disease (ESRD) patients. Methods: Between 01/1996 und 12/2006, 44 of 3293 patients undergoing aortic valve replacement (AVR) in a single institution suffered from dialysis-dependent ESRD and underwent a follow-up investigation after 1.9 years (median). Twelve (28.9 %) of these patients received a biological, 32 (71.1 %) of these patients a mechanical aortic valve prosthesis. To evaluate a possible influence of the valve type (biological/mechanical) on survival, uni- and multivariate logistic regression was used. Results: ESRD patients after AVR had a relatively poor short-term (30-day mortality: 22.7 %) and long-term survival (median survival time: 24.7 months; 95 % CI: 0.2–47.7 months), irrespective of the type of heart valve prosthesis (hazard ratio for mortality depending on heart valve type in dialysis patients: 1.31, p = 0.400). Dialysis-dependent patients were not reoperated due to valve-related reasons. Conclusions: The long-term survival of dialysis-dependent patients after AVR is low (5-year survival: 29.5 %) irrespective of the type of heart valve prosthesis. Therefore, the use of biological AVR is not contraindicated in this group of patients. Key words kidney (includes related subject matter) - heart valve surgery - cardiac - dialysis - end-stage renal disease - aortic valve replacement - biological aortic valve prosthesis - mechanical aortic valve prosthesis - long-term survival - mortality risk factors Volltext Referenzen References 1 Bonow R O, Carabello B, de Leon Jr A C et al. Guidelines for the management of patients with valvular heart disease. Executive summary. Circul. 1998; 98 1949-1984 2 Bonow R O, Carabello B A, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Circul. 2006; 114 84-231 3 Herzog C A, Ma J Z, Collins A J. Long-term survival of dialysis patients in the United States with prosthetic heart valves. Circul. 2002; 105 1336-1341 4 Bechtel J F M, Detter C, Fischlein T et al. Cardiac surgery in patients on dialysis: decreased 30-day mortality, unchanged overall survival. Ann Thorac Surg. 2008; 85 147-153 5 Toumpoulis I K, Chamogeorgakis T P, Angouras D C, Swistel D G, Anagnostopoulos C E, Rokkas C K. Independent predictors for early and long-term mortality after heart valve surgery. J Heart Valve Dis. 2008; 17 548-556 6 Rahmanian P B, Adams D H, Castillo J G, Vassalotti J, Filsoufi F. Early and late outcome of cardiac surgery in dialysis-dependent patients: single-center experience with 245 consecutive patients. J Thorac Cardiovasc Surg. 2008; 135 915-922 7 Tanaka K, Tajima K, Takami Y et al. Early and late outcome of aortic valve replacement in dialysis patients. Ann Thorac Surg. 2010; 89 65-70 8 Kajbaf S, Veinot J P, Ha A, Zimmerman D. Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population. Am J Kidney Dis. 2005; 46 86-93 9 Tarrass F, Benjelloun M, Zamd M et al. Heart valve calcifications in patients with end-stage renal disease: analysis for risk factors. Nephrology. 2006; 11 494-496 10 Maher E R, Curtis J R. Calcific aortic stenosis in chronic renal failure. Lancet. 1985; 2 1007 11 Dahm M, Dohmen G, Prüfer D, Krummenauer F, Hafner G, Oelert H. Determinants of calcium uptake of bovine pericardium for heart valve replacement: results of in vitro studies. J Heart Valve Dis. 1998; 2 170-173 12 Umezu K, Saito S, Yamazaki K, Kawai A, Kurosawa H. Cardiac valvular surgery in dialysis patients: comparison of surgical outcome for mechanical versus bioprosthetic valves. Gen Thorac Cardiovasc Surg. 2009; 57 197-202 13 Filsoufi F, Chikwe J, Castillo J G, Rahmanian P B, Vassalotti J, Adams D H. Prosthesis type has minimal impact on survival after valve surgery in patients with moderate to end-stage renal failure. Nephrol Dial Transplant. 2008; 23 3613-3621 14 Kaplon R J, Cosgrove 3rd D M, Gillinov A M, Lytle B W, Blackstone E H, Smedira N G. Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann Thorac Surg. 2002; 73 696-697 15 Toole J M, Stroud M R, Kratz J M, Crumbley A J, Crawford Jr F A, Ikonomidis J S. Valve surgery in renal dialysis patients. J Heart Valve Dis. 2006; 15 453-458 16 Lucke J C, Samy R N, Atkins B Z et al. Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. Ann Thorac Surg. 1997; 64 129-132 17 Hijashita R, Takeuchi Y. Cardiac valve replacement in patients on dialysis. Ann Thorac Surg. 2002; 73 696-697 18 Hahn H S, Maze S S. Rapid bioprosthetic valve degeneration in a patient undergoing hemodialysis. Ann Int Med. 2000; 132 847 19 Briand M, Pibarot P, Despres J P et al. Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circul. 2006; 114 (Suppl. I) I-512-I-517 20 Ohara T, Hashimoto Y, Matsumura A, Suzuki M, Isobe M. Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis. Circ J. 2005; 69 1535-1539 21 Torun D, Sezer S, Baltali M et al. Association of cardiac valve calcification and inflammation in patients on hemodialysis. Ren Fail. 2005; 27 221-226 22 Adeney K L, Siscovick D S, Ix J H et al. Association of serum phosphate with vascular and valvular calcifications in moderate CKD. J Am Soc Nephrol. 2009; 20 381-387 23 Kogan A, Medalion B, Kornowski R et al. Cardiac surgery in patients on chronic hemodialysis: short and long term survival. Thorac Cardiovasc Surg. 2008; 56 123-127 24 Brinkman W T, Williams W H, Guyton R A, Jones E L, Craver J M. Valve replacement in patients on chronic renal dialysis: implications for valve prosthesis selection. Ann Thorac Surg. 2002; 74 37-42 25 Frenken M, Krian A. Cardiovascular operations in patients with dialysis-dependent renal failure. Ann Thorac Surg. 1999; 68 887-993 26 Boku N, Masuda M, Eto M, Nishida T, Morita S, Tominaga R. Risk evaluation and midterm outcome of cardiac surgery in patients on dialysis. Asia Cardiovasc Thorac Ann. 2007; 15 19-23 Prof. Andreas Böning, MD, PHD Department of Cardiovascular SurgeryUniversity Hospital Giessen Rudolf-Buchheim-Str. 7 35385 Giessen Germany Telefon: +49 6 41 98 54 43 00 Fax: +49 6 41 98 54 43 09 eMail: andreas.boening@chiru.med.uni-giessen.de